MedPath

MAEPLE study

Not Applicable
Conditions
epilepsy
Registration Number
JPRN-jRCTs031180070
Lead Sponsor
Miyazaki Tomoyuki
Brief Summary

The primary endpoint of the study showed that there were regions of higher AMPA receptor density in PVC processed images compared to healthy subjects in both the partial and generalized seizure groups. On the other hand, no significant trend was observed in the images without PVC treatment. We also investigated the areas where EEG activity correlated with AMPA receptors and FDG-PET imaging values, as well as the areas where IQ correlated with AMPA receptors and FDG-PET imaging values. In addition, there wer

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
34
Inclusion Criteria

1. Patients diagnosed with epilepsy on the basis of ILAE criteria
2. Patients who have seizures 12months prior to registration
3. Patients without neurosurgery in the past
4. Patients who are over 20 years and below 60 years
5. Patients who can consent to this study by oneself

Exclusion Criteria

1. Patients who have experienced the electric stimulation therapy
2. Patients who have severe renal dysfunction (Serum Cre>1.5)
3. Patients who have severe liver dysfunction (AST and ALT>150)
4. Patients who have severe cardiovascular disorder
5. Patients who have tatoo
6. Claustrophobic patients
7. Patients who can not agree with contraception during 7days after [11C]K-2 PET
8. Patients who take Perampanel or Topiramate(within 1month before this registration)
9.Patients who underwent nuclear medicine examination within
1 week before this registration
10.Patients who underwent other clinical trials using unapproved
nuclear medicine examination within 6 months before this
registration
11.Patients who underwent other clinical trial within 12 weeks before this registration
12.Patients whom study doctors consider inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath